Wellgistics Health, INC S-1 registration statements

DataMeds AI, Inc. has filed an S-1 registration statement for the resale of up to 34,462,058 shares of common stock by selling stockholders, highlighting significant potential dilution.

Wellgistics Health, Inc. is offering up to 5.36 million shares and warrants to raise $6.7 million, while detailing its strategic acquisitions and a novel blockchain-based payment and potential XRP treasury strategy.

Wellgistics Health, Inc. is launching a public offering of common stock and warrants to fund its integrated healthcare ecosystem and strategic blockchain-based payment initiatives.

Wellgistics Health, a micro health ecosystem company, filed an S-1/A for a public offering of common stock and warrants, detailing recent acquisitions, a new XRP treasury strategy, and significant financial losses.

Wellgistics Health, a healthcare and pharmaceutical holding company, has filed an S-1 registration statement for a public offering of common stock and warrants, while also disclosing a new strategic plan to integrate blockchain technology and hold XRP as a primary treasury reserve asset.

Wellgistics Health has filed a registration statement for the resale of up to 3,578,254 shares of its common stock by Hudson Global Ventures, LLC, stemming from an Equity Purchase Agreement.

Wellgistics Health, a holding company focused on pharmaceuticals and healthcare services, has filed an amendment to its Form S-1 registration statement for an initial public offering of 900,000 shares of common stock, with plans to list on the Nasdaq Capital Market under the symbol WGRX.

Wellgistics Health, Inc. is seeking to raise capital through an initial public offering of 900,000 shares of common stock, with an expected price range of $4.50 to $5.50 per share, and plans to list on the Nasdaq Capital Market under the symbol WGRX.

Danam Health, Inc. has obtained a $250,000 promissory note from Strategic EP LLC, with repayment contingent on future financing or a set maturity date.

Wellgistics Health, a holding company focused on pharmaceuticals and healthcare services, has filed an S-1/A form with the SEC to register shares of its common stock for an initial public offering, with plans to list on the Nasdaq Capital Market under the symbol 'WGRX'.

Wellgistics Health, Inc. files an amendment to its Form S-1 registration statement for its initial public offering, aiming to list on the Nasdaq Capital Market under the symbol WGRX.

Danam Health, Inc. files an amendment to its Form S-1 registration statement, outlining details of its proposed initial public offering and recent acquisitions.

Danam Health, Inc. has filed an amendment to its Form S-1 registration statement for an initial public offering of its common stock, aiming to list on the Nasdaq Capital Market.

Danam Health, a holding company focused on pharmaceuticals and healthcare services, has filed an S-1 registration statement for an initial public offering (IPO) to support its growth strategy.